Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
Go back to Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate| Elite Pharmaceuticals, Inc. (AMEX: ELTP) | Delayed: 0.23 -0.01 (4.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.24 | 52 Week High | $0.42 | |||
| Open | $0.24 | 52 Week Low | $0.11 | |||
| Day High | $0.24 | P/E | N/A | |||
| Day Low | $0.23 | EPS | $-0.02 | |||
| Volume | 1,153,782 | |||||
